TMCnet News
Liquid Biopsy Markets: Global Analysis and Opportunity Evaluation 2016-2020 - Circulating Tumour Cells (CTCs) and Circulating Cell-Free DNA and RNA (cfDNA and cfRNA) - Research and MarketsResearch and Markets has announced the addition of the "Liquid Biopsy Markets: Global Analysis and Opportunity Evaluation 2016 - 2020" report to their offering. This market report gives a comprehensive and easy-to-review analysis of the liquid biopsy market 2016 - 2020. It provides key market data and identifies new and emerging opportunities relating to circulating tumour cells (CTCs) and circulating cell-free DNA and RNA (cfDNA and cfRNA). This report presents the findings of a new 'liquid biopsy' market study on CTCs, circulating cell-free nucleic acids and exosomes, completed in December 2015. These findings are analysed alongside results of a study of these markets, completed eighteen months earlier. Findings from these two studies, which present the disclosures of experienced researchers and clinicians in these fields, allowed an in-depth analysis of new developments and trends being seen in these growing diagnostic market areas. The current studies profiled 482 experienced clinicians and research scientists, and covered CTC (News - Alert) and cfDNA and cfRNA curret practices, developments, trends and three-year plans, as well as growth, shrinkage and opportunities across key areas of these diagnostic markets. Its findings provide diagnostic companies with market information on the current and evolving use or CTCs and cfDNA and cfRNA, as well as exosomes, and the techniques that are driving these developments. Key Topics Covered: Chapter 1. Background Chapter 2. Study Participants Chapter 3. Area Of Work Chapter 4. Circulating Tumour Cells Chapter 5 Circulating Cell-Free DNA And RNA (cfDNA and cfRNA) Chapter 6 Exosomes Chapter 7 Clinical Trials Chapter 8 Discussion Companies Mentioned: 35 of the 100+ companies featured in this extensive study - A&A Biotechnology - AB ANALITICA - Abbott - Abcam - ABI - Abnova - ABSciex - AccuGenomics - Aczon - Adnagen - Advanced Cell Diagnostics - AdvanDx - Affymetrix - Agendia - ALS Jena - AMNIS - Amoy Diagnostics - Angle Technology - Applied Biosystems - Argene Inc (Biomerieux) - Arrayit - Asuragen - Axygen Products - Bayer - BD - Beckman Coulter - Becton Dickinson - Biocept - BioGenex - BioLegend - Bioline - Biometra - Bioneer For more information about this report visit http://www.researchandmarkets.com/research/ht4lfp/liquid_biopsy
View source version on businesswire.com: http://www.businesswire.com/news/home/20170202005640/en/ |
